Search Results - "Rubin, D T"
-
1
Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease
Published in Alimentary pharmacology & therapeutics (01-05-2014)“…Summary Background Treatments for Crohn's disease (CD) and ulcerative colitis (UC) are not uniformly effective, thus necessitating dose changes, switching, and…”
Get full text
Journal Article -
2
Randomised clinical trial: delayed‐release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing – ASCEND I and II combined analysis
Published in Alimentary pharmacology & therapeutics (01-03-2011)“…Aliment Pharmacol Ther 2011; 33: 672–678 Summary Background Recent studies have focused on the importance of mucosal healing in ulcerative colitis (UC)…”
Get full text
Journal Article -
3
Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
Published in Alimentary pharmacology & therapeutics (01-02-2009)“…Summary Background Ulcerative colitis (UC) can be maintained in remission with 5‐aminosalicylic acid (5‐ASA) medications, but frequent non‐adherence by…”
Get full text
Journal Article -
4
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
Published in Alimentary pharmacology & therapeutics (01-03-2013)“…Summary Background Current approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (IBD‐CRN) are suboptimal. Aim To test…”
Get full text
Journal Article -
5
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program
Published in Clinical pharmacology and therapeutics (01-07-2017)“…Despite growing clinical use of genomic information, patient perceptions of genomic‐based care are poorly understood. We prospectively studied…”
Get full text
Journal Article -
6
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Published in Alimentary pharmacology & therapeutics (01-03-2018)“…Summary Background Blocking of lymphocyte trafficking to bile ducts is a potential mechanism to alter the disease course of patients with primary sclerosing…”
Get full text
Journal Article -
7
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply
Published in Alimentary pharmacology & therapeutics (01-05-2018)“…Linked Content This article is linked to Christensen et al and Pavlidis et al papers. To view these articles visit https://doi.org/10.1111/apt.14525 and…”
Get full text
Journal Article -
8
Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial
Published in Alimentary pharmacology & therapeutics (01-01-2017)“…Summary Background Health‐related quality of life (HRQL) is often diminished in patients with ulcerative colitis. Aim To evaluate the effects of vedolizumab on…”
Get full text
Journal Article -
9
Smoking and inflammatory bowel disease
Published in European journal of gastroenterology & hepatology (01-08-2000)“…It is well established that smoking cigarettes is associated with Crohn's disease (CD) and that non-smoking is associated with ulcerative colitis (UC)…”
Get more information
Journal Article -
10
CT colonography with three-dimensional problem solving for detection of colonic polyps
Published in American journal of roentgenology (1976) (01-10-1998)“…We performed CT colonography in patients referred for conventional colonoscopy, interpreted the axial images, and used commercially available software to…”
Get full text
Journal Article -
11
Ethics of a Paired-Kidney-Exchange Program
Published in The New England journal of medicine (12-06-1997)“…Although transplantation is the best treatment for many people with end-stage renal disease, the gap between the number of organ donors and the number of…”
Get full text
Journal Article -
12
Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison
Published in The Lancet (British edition) (22-01-2005)“…The usefulness of currently available colon imaging tests, including air contrast barium enema (ACBE), computed tomographic colonography (CTC), and…”
Get full text
Journal Article -
13
Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts
Published in NMR in biomedicine (01-07-2009)“…Colorectal cancer is one of the most common cancers in the western world. Its early detection has been found to improve the prognosis of the patient, providing…”
Get full text
Journal Article -
14
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Published in The American journal of gastroenterology (01-09-2015)“…The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory…”
Get full text
Journal Article -
15
P221 Intestinal ultrasound is predictive of disease relapse in asymptomatic Inflammatory Bowel Disease patients
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Intestinal ultrasound (IUS) is a non-invasive, repeatable, and accurate disease monitoring modality that provides real-time assessment of…”
Get full text
Journal Article -
16
P975 Monitoring Inflammatory Bowel Disease (IBD) by intestinal ultrasound decreases time to treatment change and time to remission in comparison to conventional management: Analysis of patients with IBD on multiple IBD therapies
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Intestinal ultrasound (IUS) is a non-invasive, repeatable, and accurate disease monitoring modality that can provide real-time assessment…”
Get full text
Journal Article -
17
P543 Patients in trials of moderate-to-severe UC who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Ulcerative Colitis (UC) is a relapsing-remitting inflammatory disease of the colon and rectum. There are many challenges to the recruitment…”
Get full text
Journal Article -
18
P787 Use of upadacitinib to treat IBD in post-liver transplant
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Approximately 2% of patients with inflammatory bowel disease (IBD) have concurrent primary sclerosing cholangitis (PSC). Liver…”
Get full text
Journal Article -
19
P982 Patients in trials of moderate-to-severe CD who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Crohn’s disease (CD) is a relapsing-remitting inflammatory disease of the gastrointestinal tract characterized by a progressive nature and…”
Get full text
Journal Article -
20
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
Published in Gut (01-07-2011)“…Recommendations for venous thromboembolism (VTE) prophylaxis in patients with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific…”
Get more information
Journal Article